Pharmacovigilance data
Broadening access to signal is a positive step, but access to VigiBase is also needed
read (161 KB)
ISDB General Assembly Meeting - 2012
for members only
Press Release - EMEA & other regulatory issues
EMA transparency draft is just window dressing
HAI Europe, ISDB and MiEF find that “EMEA’s draft transparency policy” fails to restore citizens’ trust in its decision-making.
Health Action International (HAI) Europe, International Society of Drug Bulletins (ISDB) and Medicine in Europe Forum (MiEF) find that “EMEA’s draft transparency policy” fails to restore citizens’ trust in its decision-making.
Latest Press Release
-
EU Parliament says no and no again to EMA:...
May 15th 2012 - EMEA & other regulatory issues
-
Pharmacovigilance data
February 15th 2012 - Other issues
Broadening access to signal is a positive step, but access to VigiBase is also needed
-
Revised proposal for a Directive on...
December 1st 2011 - DTCA & Pharmaceutical package
Some improvements, but risks of DTCA (direct-to-consumer advertising) remain
read english (
-
Joint analysis
October 21st 2011 - DTCA & Pharmaceutical package
Revised proposals on "information" to patients: still an open door to advertising of prescription-only medicines by pharmaceutical...
-
Parliament’s stand against conflicts of...
May 10th 2011 - EMEA & other regulatory issues
ISDB - International Society of Drug bullettins
Contact details:
President: president@isdbweb.org
Webmaster: maria.font@ulss20.verona.it
© 2012